Electromagnetic fields (EMFs) might be a safe and non-invasive way to manage blood glucose in diabetes, say researchers who examined the effects of EMFs in altering the balance of oxidants and antioxidants in the liver and causing an improvement in the body’s response to insulin. Read more
The possible role of Vitamin D levels contributing to diabetes risk has been much discussed. A recent study has found that deficiencies in Vitamin D are not linked to an increased risk of developing type 1 diabetes in Europeans. Read more
The risk of dying from COVID-19 infection is higher in middle-aged adults with type 2 diabetes versus adults without diabetes, and is the equivalent of adding 20 years of chronological age in assessing overall related death risk. Read more
Glycated hemoglobin (A1c) testing is a standard method of assessing blood glucose levels in people with diabetes. However, researchers are finding that iron deficiency or vitamin B12 deficiency anemia can affect A1c testing results. Read more
Diabetes has already been linked with dementia and cognitive decline. Now, researchers say people with prediabetes also have a higher risk of cognitive decline and vascular dementia, even in the absence of full-blown diabetes, stressing the importance of glycemic control in preventing these conditions. Read more
Some athletes now embrace a strategy called “low CHO availability“ to potentially improve their performance, which involves training low-carb and competing high-carb — periodically doing endurance training with reduced carbohydrate availability, but competing without carbohydrate intake restrictions. Diabetes exercise expert Dr. Sheri Colberg takes a closer look at the implications. Read more
Obstructive sleep apnea (OSA), insomnia, and diabetes are often linked and can have an impact on quality of life, worsening the risk for stress and depression. New research suggests the impact is worse on people under the age of sixty-five who experience diabetes and OSA. Read more
Studies of diabetes drugs empagliflozin and dapagliflozin, both in the SGLT-2 inhibitor class, have shown they help reduce cardiovascular risk for diabetes patients. Now, researchers have found that empagliflozin is beneficial for the heart in people without diabetes as well. Read more
Technology has changed managing type 1 diabetes dramatically over the last 20 years, for both children and adults. Good glucose management is key to preventing many complications of diabetes, and this has been made much easier with the use of continuous glucose monitors, new pump designs, and closed-loop systems. Read more
Having a dog that is diagnosed with diabetes was related to a increased risk of type 2 diabetes in the owner, a recent study found. Potential causes of this link in dog-owner pairs might possibly have something to do with shared health habits, such as physical activity level, and shared environmental exposures. Read more
People with diabetes are at higher risk of death from the COVID-19 virus at younger ages than people without diabetes, researchers say, and should be prioritized for the vaccine from age 40 and up. Read more
The diabetes drug semaglutide, administered once-weekly subcutaneously and used in conjunction with lifestyle modifications, helped people with overweight or obesity achieve sustained, significant reductions in body weight. Read more
A clinical trial of a new stem cell-derived pancreatic islet cell treatment for type 1 diabetes, by Vertex Pharmaceuticals, is moving forward. According to Vertex, the therapy, called VX-880, has the potential to restore the body’s ability to normalize blood glucose levels through restoration of pancreatic islet cell function. Read more
People who suffer from social deprivation, which can be caused by factors including poverty and mental illness, and who have type 2 diabetes are at greater risk for complications of diabetic foot disease, including diabetic foot ulcers, lower limb amputation, and gangrene. Read more
Type 2 diabetes is the condition that results when β-cells (beta cells) cannot release enough insulin for the body’s needs. A group of researchers say they have new insight into how “weak” beta cells bond with other, more mature cells to boost insulin production, which can help us understand more about the processes that lead […]
Some metabolic conditions, including type 2 diabetes, can increase the risk of severe non-alcoholic fatty liver disease (NAFLD), a condition which can cause inflammation, cirrhosis, and possibly liver cancer. People with type 2 diabetes have twice the risk of severe liver disease than people without type 2, researchers say. Read more
Both the Moderna and Pfizer vaccine trials included people with diabetes, and found the vaccine does not interact with diabetic medications or cause problems with overall diabetes control, experts say. However, the immune response to the vaccine can cause temporary elevation in blood glucose levels, so people with diabetes should carefully monitor their glucose for […]
Severe hypoglycemia can lead to fatal complications, including heart arrhythmias, seizures, and coma. Research has also found that patients with hypoglycemic events severe enough to require medical assistance also had increased risk of developing cancer and skin, respiratory, and digestive complications. Read more
Eli Lilly is expanding its existing type 1 diabetes partnership with Life for a Child, with the goal of supporting more than six times as many children in the next 10 years. Lilly plans to expand care to 150,000 young people with diabetes over the next decade, providing free medicine and equipment like reusable pens […]
Insulin is the mainstay treatment for patients with type 2 diabetes who also have beta-cell failure; however, some insulin regimens can be complicated to manage and may increase the risk of hypoglycemia. Now, researchers say that a simple add-on therapy with the GLP-1 Agonist medication albiglutide can reduce insulin use for patients with type 2 […]